Paul M O'Byrne Selected Research

Formoterol Fumarate (Oxis)

1/2022	A patient decision aid for mild asthma: Navigating a new asthma treatment paradigm.
12/2021	Positioning As-needed Budesonide-Formoterol for Mild Asthma: Effect of Prestudy Treatment in Pooled Analysis of SYGMA 1 and 2.
11/2021	Reply to "As-needed budesonide-formoterol for adolescents with mild asthma: importance of lung function".
10/2021	The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada.
1/2021	Efficacy and Safety of As-Needed Budesonide-Formoterol in Adolescents with Mild Asthma.
1/2021	Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study.
1/2021	The management of mild asthma.
1/2021	Safety of As-Needed Budesonide-Formoterol in Mild Asthma: Data from the Two Phase III SYGMA Studies.
8/2020	Inhaled corticosteroids/formoterol as a reliever in mild asthma.
1/2020	What have we learnt about asthma control from trials of budesonide/formoterol as maintenance and reliever?

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul M O'Byrne Research Topics

Disease

169	Asthma (Bronchial Asthma) 05/2024 - 01/2002
47	Inflammation (Inflammations) 02/2023 - 01/2002
26	Respiratory Hypersensitivity 01/2023 - 02/2002
18	Eosinophilia 10/2023 - 07/2002
11	Cough 11/2023 - 07/2015
8	Chronic Obstructive Pulmonary Disease (COPD) 08/2015 - 08/2009
6	Chronic Cough 02/2024 - 01/2020
6	Allergic Rhinitis 11/2023 - 08/2002
5	Airway Remodeling 01/2022 - 11/2002
3	Hypersensitivity (Allergy) 11/2023 - 08/2003
3	Pneumonia (Pneumonitis) 09/2015 - 07/2006
2	Infections 01/2014 - 01/2012
2	Rhinitis 03/2004 - 08/2002
1	Neoplasms (Cancer) 04/2024
1	Dysbiosis 04/2024
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 04/2024
1	Tuberculosis (Tuberculoses) 01/2022
1	Dysphonia (Spastic Dysphonia) 06/2021
1	Bronchitis 01/2020
1	Gastroesophageal Reflux (GERD) 01/2020
1	Dyspnea (Shortness of Breath) 01/2020

Drug/Important Bio-Agent (IBA)

71	AllergensIBA 04/2024 - 01/2002
60	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 07/2002
36	Budesonide (Pulmicort)FDA LinkGeneric 01/2022 - 07/2002
27	Formoterol Fumarate (Oxis)FDA Link 01/2022 - 01/2004
20	CytokinesIBA 05/2024 - 07/2002
13	SteroidsIBA 01/2020 - 01/2003
13	Interleukin-5 (Interleukin 5)IBA 01/2016 - 07/2002
12	Methacholine Chloride (Methacholine)FDA Link 01/2021 - 11/2002
11	Interleukin-13IBA 11/2023 - 04/2004
10	fluticasone furoate FDA Link 01/2020 - 06/2013
9	Terbutaline (Brethaire)FDA LinkGeneric 12/2021 - 01/2005
9	Immunoglobulin E (IgE)IBA 03/2017 - 08/2002
8	Monoclonal AntibodiesIBA 02/2023 - 03/2009
8	vilanterolIBA 01/2020 - 06/2013
7	Bronchodilator Agents (Bronchodilators)IBA 12/2021 - 08/2015
7	Formoterol Fumarate Drug Combination Budesonide FDA Link 12/2021 - 01/2004
7	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 10/2021 - 01/2005
7	anti-IgE antibodiesIBA 01/2017 - 08/2002
6	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 12/2021 - 01/2004
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2017 - 02/2007
5	Thymic Stromal LymphopoietinIBA 02/2023 - 05/2014
5	InterleukinsIBA 01/2023 - 07/2002
5	Interleukin-33IBA 01/2023 - 06/2015
5	Prednisone (Sone)FDA LinkGeneric 10/2020 - 04/2003
4	AlarminsIBA 04/2024 - 01/2017
4	Biomarkers (Surrogate Marker)IBA 11/2023 - 04/2009
4	Capsaicin (Zostrix)FDA Link 01/2021 - 03/2017
4	Fluticasone (Cutivate)FDA LinkGeneric 01/2020 - 02/2011
4	GlucocorticoidsIBA 06/2018 - 01/2016
4	Omalizumab (Xolair)FDA Link 01/2017 - 08/2002
3	Immunoglobulins (Immunoglobulin)IBA 05/2024 - 06/2008
3	tezepelumabIBA 02/2023 - 01/2023
3	Salmeterol Xinafoate (Serevent)FDA Link 06/2014 - 02/2011
3	Interleukin-18 ReceptorsIBA 01/2014 - 01/2013
3	OvalbuminIBA 01/2012 - 07/2002
3	LeukotrienesIBA 09/2009 - 07/2002
3	Interleukin-4 (Interleukin 4)IBA 07/2006 - 04/2004
2	benralizumabIBA 10/2023 - 01/2016
2	AntibodiesIBA 10/2023 - 01/2014
2	Immunoglobulin FragmentsIBA 02/2023 - 01/2023
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2021 - 05/2002
2	Interleukin-17 (Interleukin 17)IBA 01/2018 - 01/2014
2	Cholinergic Antagonists (Anticholinergics)IBA 08/2016 - 01/2012
2	Humanized Monoclonal AntibodiesIBA 01/2016 - 01/2013
2	mepolizumabIBA 01/2016 - 03/2009
2	PeriostinIBA 01/2016 - 09/2015
2	AntigensIBA 01/2014 - 01/2012
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 09/2002
2	ciclesonide FDA Link 02/2011 - 08/2005
2	Interleukin-10 (Interleukin 10)IBA 11/2008 - 02/2002
2	Messenger RNA (mRNA)IBA 05/2008 - 09/2002
2	montelukast (Singulair)FDA Link 09/2006 - 11/2002
2	ChemokinesIBA 03/2005 - 08/2003
2	pranlukastIBA 07/2004 - 04/2004
2	Histamine Antagonists (Antihistamines)IBA 03/2004 - 07/2002
1	neuromedin UIBA 04/2024
1	NeuropeptidesIBA 04/2024
1	Tryptases (Tryptase)IBA 11/2023
1	GefapixantIBA 10/2023
1	AerosolsIBA 01/2022
1	VaccinesIBA 01/2022
1	A 7 (A-7)IBA 06/2021
1	Muscarinic AntagonistsIBA 06/2021
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 01/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 10/2020
1	AutoantibodiesIBA 10/2020
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2020
1	Purinergic P2X3 ReceptorsIBA 01/2020
1	prednylidene (Pred)IBA 01/2020

Therapy/Procedure

62	Therapeutics 05/2024 - 07/2002
6	Nebulizers and Vaporizers (Inhaler) 06/2021 - 01/2004
4	Drug Therapy (Chemotherapy) 01/2017 - 10/2007
2	Activities of Daily Living (ADL) 02/2024 - 11/2023
2	Biological Therapy 02/2023 - 01/2023
2	Aftercare (After-Treatment) 01/2021 - 11/2008
2	Precision Medicine 01/2017 - 01/2016
2	Emergency Treatment 01/2017 - 01/2009
1	Airway Management 01/2022
1	Language Therapy (Language Training) 01/2020